Asset Details
Do you wish to reserve the book?
Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry
Do you wish to request the book?
Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry
2017
Overview
Background
The INSIGHTS-IPF registry provides one of the largest data sets of clinical data and self-reported patient related outcomes including health related quality of life (QoL) on patients with idiopathic pulmonary fibrosis (IPF). We aimed to describe associations of various QoL instruments between each other and with patient characteristics at baseline.
Methods
Six hundred twenty-three IPF patients with available QoL data (St George’s Respiratory Questionnaire SGRQ, UCSD Shortness-of-Breath Questionnaire SoB, EuroQol visual analogue scale and index EQ-5D, Well-being Index WHO-5) were analysed. Mean age was 69.6 ± 8.7 years, 77% were males, mean disease duration 2.0 ± 3.3 years, FVC pred was 67.5 ± 17.8%, DL
CO
pred 35.6 ± 17%.
Results
Mean points were SGRQ total 48.3, UCSD SoB 47.8, EQ-5D VAS 66.8, and WHO-5 13.9. These instruments had a high or very high correlation (exception WHO-5 to EQ-5D VAS with moderate correlation). On bivariate analysis, QoL by SGRQ total was statistically significantly associated with clinical symptoms (NYHA;
p
< 0.001), number of comorbidities (
p
< 0.05), hospitalisation rate (
p
< 0.01) and disease severity (as measured by GAP score, CPI, FVC and 6-min walk test;
p
< 0.05 each). Multivariate analyses showed a significant association between QoL (by SGRQ total) and IPF duration, FVC, age, NYHA class and indication for long-term oxygen treatment.
Conclusions
Overall, IPF patients under real-life conditions have lower QoL compared to those in clinical studies. There is a meaningful relationship between QoL and various patient characteristics.
Trial registration
The INSIGHTS-IPF registry is registered at Clinicaltrials.gov (
NCT01695408
).
Publisher
BioMed Central,BioMed Central Ltd,Nature Publishing Group,BMC
Subject
/ Aged
/ Complications and side effects
/ Dyspnea
/ Female
/ Fibrosis
/ Humans
/ Idiopathic pulmonary fibrosis
/ Idiopathic Pulmonary Fibrosis - diagnosis
/ Idiopathic Pulmonary Fibrosis - physiopathology
/ Idiopathic Pulmonary Fibrosis - psychology
/ Male
/ Medicine
/ Patient Reported Outcome Measures
/ Patients
/ Pneumology/Respiratory System
/ Thorax
